Trejo WH, Bennett RE. Streptomyces nodosus sp. n., the amphotericin-producing organism. J Bacteriol. 1963;85:436–9.
Article CAS PubMed PubMed Central Google Scholar
Aversa F, Busca A, Candoni A, Cesaro S, Girmenia C, Luppi M, Nosari AM, Pagano L, Romani L, Rossi G, Venditti A, Novelli A. Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use. J Chemother. 2017;29:131–43.
Article CAS PubMed Google Scholar
Stone NR, Bicanic T, Salim R, Hope W. Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions. Drugs 2016;76:485–500.
Article CAS PubMed PubMed Central Google Scholar
Uchida R, Kondo A, Yagi A, Nonaka K, Masuma R, Kobayashi K, Tomoda H. Simpotentin, a new potentiator of amphotericin B activity against Candida albicans, produced by Simplicillium minatense FKI-4981. J Antibiot. 2019;72:134–40.
Fukuda T, Nagai K, Yagi A, Kobayashi K, Uchida R, Yasuhara T, Tomoda H. Nectriatide, a Potentiator of Amphotericin B Activity from Nectriaceae sp. BF-0114. J Nat Prod. 2019;82:2673–81.
Article CAS PubMed Google Scholar
Yagi Y, Uchida R, Kobayashi K, Tomoda H. Polyketide glycosides phialotides A to H, new potentiators of amphotericin B activity, produced by Pseudophialophora sp. BF-0158. J Antibiot. 2020;73:211–23.
Ishijima H, Uchida R, Ohtawa M, Kondo A, Nagai K, Shima K, Nonaka K, Masuma R, Iwamoto S, Onodera H, Nagamitsu T, Tomoda H. Simplifungin and Valsafungins, Antifungal Antibiotics of Fungal Origin. J Org Chem. 2016;81:7373–83.
Article CAS PubMed Google Scholar
Clinical and Laboratory Standards Institute (CLSI): Reference method for broth dilution antifungal susceptibility testing of yeasts. 4rd ed; CLSI document M27-A4. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
Clinical and Laboratory Standards Institute (CLSI): Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard CLSI document M38-A3. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
Clinical and Laboratory Standards Institute (CLSI): Reference methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard CLSI document M07-A9. 9th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
Kimura K, Nakayama S, Nakajima N, Yoshihama M, Miyata N, Kawanishi G. A new piericidin rhamnoside, 3’-rhamnopiericidin A1. J Antibiot. 1990;43:1341–3.
Tamura S, Takahashi N, Miyamoto S, Mori R, Suzuki S, Nagatsu J. Isolation and physiological activities of piericidin A, a natural insecticide produced by Streptomyces. Agr Biol Chem. 1963;2:576–82.
Schnermann MJ, Romero FA, Hwang I, Nakamaru-Ogiso E, Yagi T, Boger DL. Total synthesis of piericidin A1 and B1 and key analogues. J Am Chem Soc. 2006;128:11799–807.
Article CAS PubMed PubMed Central Google Scholar
Bock K, Lundt I, Pedersen C. Assignment of anomer structure to carbohydrates through geminal 13C-1H coupling constants. Tetrahedron Lett. 1973;13:1037–40.
Tanaka T, Nakashima T, Ueda T, Tomii K, Kouno I. Facile discrimination of aldose enantiomers by reversed-phase HPLC. Chem Pharm Bull. 2007;55:899–901.
Azad SM, Jin Y, Ser HL, Goh BH, Lee LH, Thawai C, He YW. Biological insights into the piericidin family of microbial metabolites. J Appl Microbiol. 2022;132:772–84.
Article CAS PubMed Google Scholar
Takahashi N, Suzuki A, Kimura Y, Miyamoto S, Tamura S, Mitsui T, Fukami J. Isolation, structure and physiological activities of piericidin B, natural insecticide produced by a Streptomyces. Agr Biol Chem. 1968;32:1115–22.
Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I), Friedrich T, van Heek P, Leif H, Ohnishi T, Forche E, Kunze B, Jansen R, Trowitzsch-Kienast W, Höfle G, Reichenbach H, Weiss H. Eur J Biochem. 1994;219:691–8.
留言 (0)